Orhub’s Ryan Fernan Becomes Head Of Pur Biologics, Leading Regenerative Therapeutic Efforts
Go back to Orhub’s Ryan Fernan Becomes Head Of Pur Biologics, Leading Regenerative Therapeutic Efforts| Baxter International Inc. (NYSE: BAX) | Delayed: 24.93 -0.9 (3.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.83 | 52 Week High | $50.16 | |||
| Open | $25.59 | 52 Week Low | $34.06 | |||
| Day High | $25.75 | P/E | 6.81 | |||
| Day Low | $24.84 | EPS | $3.66 | |||
| Volume | 1,144,266 | |||||
| (AMEX: HSTO) | Delayed: 0.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.22 | 52 Week High | $ | |||
| Open | $0.22 | 52 Week Low | $ | |||
| Day High | $0.22 | P/E | N/A | |||
| Day Low | $0.22 | EPS | $ | |||
| Volume | 278,368 | |||||
